Aquatic Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Aquatic Capital Management's AXSM Position: Q3 2026 in Review
Aquatic Capital Management sold out of Axsome Therapeutics (AXSM) in Q3 2026, closing a stake of 16,297 shares — an estimated $3.99M sold.
Aquatic Capital Management first reported a position in AXSM in Q1 2022 and held it in 9 quarters. The position peaked at $5.53M in Q1 2025. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Aquatic Capital Management reported no remaining Axsome Therapeutics position as of Q3 2026 after selling out during the quarter.
- Aquatic Capital Management sold 16,297 Axsome Therapeutics shares in Q3 2026, an estimated $3.99M.
- Aquatic Capital Management first reported a position in Axsome Therapeutics in Q1 2022 and held it in 9 quarters.
- Aquatic Capital Management's Axsome Therapeutics position peaked at $5.53M in Q1 2025.
- 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Aquatic Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.